Accepted for Publication: May 21, 2012.
Published Online: July 9, 2012. doi:10.1001/archinternmed.2012.3093
Author Contributions: Drs Amin, Spertus, and Yeh, Mr Kennedy, and Ms Vilain had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Amin, Spertus, Cohen, Chhatriwalla, Vilain, Lai, Normand, and Yeh. Acquisition of data: Amin, Spertus, and Messenger. Analysis and interpretation of data: Amin, Spertus, Chhatriwalla, Kennedy, Salisbury, Venkitachalam, Lai, Mauri, Rumsfeld, Messenger, and Yeh. Drafting of the manuscript: Amin, Chhatriwalla, and Yeh. Critical revision of the manuscript for important intellectual content: Amin, Spertus, Cohen, Chhatriwalla, Kennedy, Vilain, Salisbury, Venkitachalam, Lai, Mauri, Normand, Rumsfeld, Messenger, and Yeh. Statistical analysis: Amin, Kennedy, and Lai. Obtained funding: Spertus. Administrative, technical, and material support: Spertus, Vilain, Rumsfeld, and Messenger. Study supervision: Spertus, Chhatriwalla, Lai, and Mauri. Interpretation of statistics: Normand.
Financial Disclosure: Dr Spertus is the primary investigator of a contract from the American College of Cardiology Foundation to serve as an Analytic Center for the NCDR. He also has an equity position in Health Outcomes Sciences. Dr David J. Cohen has received research grant support from Boston Scientific, Medtronic, Abbott Vascular, Eli Lilly, Daichi Sankyo, Accumetrix, BMS/Sanofi, Schering-Plough, and Edwards Lifesciences. He has also received consulting fees from Cordis and Medtronic and speaking honoraria from Eli Lilly and the Medicines Company. Dr Mauri receives institutional research support from Abbott, Boston Scientific, Cordis, Medtronic, Eli Lilly, Daiichi Sankyo, Bristol Myers Squibb, and sanofi-aventis and has consulted for Cordis and Medtronic. Dr Rumsfeld is Chief Science Officer for the NCDR. Dr Yeh is an investigator for the Harvard Clinical Research Institute and a consultant for the Kaiser Permanente Division of Research.
Funding/Support: Funding for the ACC NCDR CathPCI registry was provided by grants from the American College of Cardiology Foundation. This analysis was funded by the ACC. This research was supported by the American College of Cardiology Foundation National Cardiovascular Data Registry (NCDR). Dr Amin is funded, in part, by an award from the American Heart Association Pharmaceutical Round Table and David and Stevie Spina.
Role of the Sponsor: No sponsor participated in the design and conduct of the study; collection, analysis, or interpretation of the data; nor in the preparation, review, nor approval of the manuscript.